細胞外小胞 (EV) は粒径と biogenesis に基づき、後期エンドソーム由来 exosome (30–150 nm)、形質膜出芽 microvesicle/ectosome (100–1000 nm)、アポトーシス小体、前立腺癌などで報告された large oncosome (1–10 µm)、migrasome へと分類され、近年は非対称流場流分画法で小型 EV と区別される非小胞性ナノ粒子 exomere (約45 nm)・supermere (約35 nm) が独立した一群として加わった (Kalluri et al. Cell 2023)。MISEV (Minimal Information for Studies of Extracellular Vesicles) ガイドラインはマーカー単独で亜集団を断定せず、サイズ・浮遊密度・複数マーカー (CD9/CD63/CD81) による定義を運用標準とした (Thery et al. JExtracellVesicles 2018)。EV 組成の再検証では従来 exosome マーカーとされた分子の一部が非小胞性画分に由来することが示され (Jeppesen et al. Cell 2019)、ESCRT (Endosomal Sorting Complex Required for Transport) 依存／非依存の MVB (multivesicular body) 経路・Rab による分泌制御を含む cell-cell communication の方法論的枠組も整理が進んだ (vanNiel et al. NatRevMolCellBiol 2022)。large EV (large oncosome) 産生の上流ドライバーとしては、染色体不安定性に伴う細胞質 DNA が cGAS-STING を活性化し、TBK1/IKKβ 非依存的な JNK-FAK 軸を介して膜 blebbing と large EV 放出を駆動する進化的に保存された経路が同定され、large EV 自体が cGAS を運搬して受容免疫細胞の STING を全身的に活性化することが Drosophila とヒトがん細胞株で示された (Lee et al. JExtracellVesicles 2026)。
がん EV の機能は cargo (miRNA、mRNA、タンパク質、dsDNA、脂質) が受容細胞のシグナルと形質を再プログラムする点に集約される。変異 KRAS は AGO2 の多小胞体集積を阻害して EV への miRNA パッケージングを改変し、exosome 生合成と癌遺伝子をリンクさせる (Kalluri et al. Cell 2023)。間質由来 EV は抗ウイルス様 STAT1 シグナルを介して治療抵抗性を誘導し (Boelens et al. Cell 2014)、乳癌分泌 miR-105 は血管内皮バリアを破壊して転移を促進する (Zhou et al. CancerCell 2014)。biogenesis 制御では CD63 がコレステロールをエンドソームへ仕分けして exosome 経由で分配する経路も同定され、tetraspanin が単なるマーカーを超えた cargo 選別機能を担うことが明らかになった (Palmulli et al. NatCellBiol 2024)。
Pre-metastatic niche (PMN) 形成は EV 研究の中核パラダイムである。メラノーマ exosome は骨髄前駆細胞を MET 経由で pro-metastatic に教育し (Peinado et al. NatMed 2012)、腫瘍 exosome の integrin α6β4/α6β1 は肺、αvβ5 は肝への臓器親和性を決定し、標的細胞で Src リン酸化と S100 遺伝子群を誘導して niche を構築する (Hoshino et al. Nature 2015)。膵癌 exosome は MIF (macrophage migration inhibitory factor) 依存的に肝 PMN を形成し (Costa-Silva et al. NatCellBiol 2015)、肺では腫瘍 exosomal RNA が肺胞上皮 TLR3 を介して好中球を誘引する (Liu et al. CancerCell 2016)。近年この paradigm は cancer-induced systemic pre-conditioning として遠隔臓器横断のフレームに統合され (Rabas et al. NatRevCancer 2024)、ヒト早期膵癌の術中肝生検では SORT1 高発現・NETs (neutrophil extracellular traps)・CD11B+ NK 細胞・機能不全 T 細胞の複合 signature が早期肝転移を予測し、機械学習モデルが術時に転移転帰を 78% (早期肝転移 90%) で判別できることが示された (Bojmar et al. NatMed 2024)。さらに転移巣に隣接する非転移肺では CXCL13 で再プログラムされた間質マクロファージが integrin β2 集積 sEV を産生し、αXβ2-GPIb 軸の組織因子非依存的な血小板凝集で癌関連血栓症と転移を同時に駆動する「pro-thrombotic niche」が定義され、抗 β2 抗体が出血リスクなしに血栓を約50%・転移を約75%抑制し生存を約50%延長した (Lucotti et al. Cell 2025)。
Tumor–immune crosstalk では exosomal PD-L1 の抑制が全身抗腫瘍免疫と記憶を誘導し (Poggio et al. Cell 2019)、IFN (interferon) 駆動の oxysterol が EV 取り込みを防御する (Ortiz et al. CancerCell 2019) など、EV-免疫系の統合像が整理されてきた (Buzas et al. NatRevImmunol 2023)。直近の知見は免疫回避機構の多様化を示す。腫瘍 EV 由来 PD-L1 は T 細胞に DNA 損傷と CREB/脂質代謝リプログラミングを誘導して T 細胞老化を引き起こし、GW4869・コレステロール合成阻害が CAR-T (chimeric antigen receptor T) / 抗 PD-L1 効果を増強する (Ma et al. SciTranslMed 2025)。三重陰性乳癌のがん幹細胞由来 TSPAN8 陽性 EV は cargo 取り込みに依存せず、膜表面 TSPAN8 が組織常在性 T 細胞の CD103 (integrin αEβ7) と結合して MAP4K4-LKB1-AMPK 経路を介し FOXP3 を誘導し、CD103+FOXP3+ Treg の分化・増殖を駆動するという非カノニカル機序が示され、血漿 EV の TSPAN8 高値は免疫療法抵抗性 (病理学的完全奏効 pCR (pathologic complete response) 14% vs 51%) と相関し、抗 TSPAN8 抗体と抗 PD-1 の併用が前臨床で相乗効果を示した (Fan et al. CancerCell 2026)。こうした「cargo を内在化させず表面リガンドで受容細胞の運命を指示する EV」は tumor whisperer として概念化され、非カノニカル EV signaling が免疫回避研究の新パラダイムに位置づけられた (Hendrix et al. CancerCell 2026)。メラノーマでは MHC (major histocompatibility complex) class I と腫瘍抗原を載せた大型 EV (メラノソーム) が CD8+ T 細胞の TCR (T cell receptor) を不完全に刺激してミトコンドリア機能不全とアポトーシスへ誘導する「デコイ」機構も報告された (Chemla et al. Cell 2026)。脳転移では EV cargo S100A14 が astrocyte を PIAS3 経路で reprogram して免疫抑制を誘導するなど (Feng et al. AdvSci 2026)、organotropism × 免疫リプログラミングの解像度が高まっている (Kovacs et al. NatRevImmunol 2025)。
EV は免疫抑制側だけでなく免疫賦活側のメディエーターでもあるという両義性が、直近の知見で明確になった。活性化 T 細胞由来 EV (AT-EV, activated T cell-derived EV) は新規合成された抗原提示関連遺伝子座 (MHC、TAP (transporter associated with antigen processing)、免疫プロテアソーム) に富むゲノム DNA を選択的にパッケージし、granzyme B が受容細胞の核ラミンを切断して核内へ DNA を送達することで MHC・抗原提示経路をエピソーム的に一過性に増強し、膠芽腫・膵癌・乳癌の cold tumor を hot 化して抗 PD-1 と相乗するという「acellular immunotherapy」のパラダイムが提示された (Hu et al. CancerCell 2026)。神経芽腫では腫瘍由来 EV が CAR 標的 GPC2/GD2 を提示し PD-L1 をほとんど持たないため CAR-T を直接活性化し、RAB27A KO・GW4869 で EV 分泌を断つと CAR-T 有効性が低下する一方、アルブミン結合や抗 GD2 で武装した合成 EV (SyntEVs) が CAR-T の末梢持続性・腫瘍浸潤・抗腫瘍効果を増強した (Giudice et al. SciTranslMed 2025)。これらは EV の免疫学的作用が cargo・表面分子・産生細胞種・受容細胞の文脈に強く依存することを示し、免疫抑制を遮断する戦略と免疫賦活 EV を治療に転用する戦略の双方を裏づける。
Liquid biopsy では pan-cancer の EVP (extracellular vesicle and particle) proteome biomarker が参照データセットとして確立し (Hoshino et al. Cell 2020)、臨床側では尿 EV 遺伝子発現アッセイ ExoDx Prostate (IntelliScore) が 1,094 例の RCT (randomized controlled trial) で低リスク群の不要生検を 79.0% から 44.6% へ低減して FDA (US Food and Drug Administration) Breakthrough Device に到達し、GPC1+CA19-9 が早期膵癌を特異度 91.3% で検出、ナノプラズモン多重プラットフォーム (TPEX) は 1 µL を 15 分で多重測定し AUC (area under the curve) 0.97 を達成した (Greening et al. NatRevClinOncol 2025)。治療では KRAS G12D 標的 siRNA (small interfering RNA) を載せた iExosomes、exoSTING、exoIL-12、exoASO-STAT6 が Phase I/II で安全性・忍容性を確認しており (Kalluri et al. Cell 2023)、抗原提示 EV や DC (dendritic cell)-EV ワクチン (pMHC-I / 抗 PD-1 / B7 提示 ADC-EV が LLC (Lewis lung carcinoma) で 80% 腫瘍退縮) など engineered EV platform も拡大した (Giudice et al. SciTranslMed 2025)。一方で EV の不均一性、分離・精製の標準化不足、GMP (Good Manufacturing Practice) 製造とロット間均質性、長期免疫原性に関する規制的枠組は未整備のままであり、臨床実装の主要ボトルネックとして残る (Greening et al. NatRevClinOncol 2025)。
腫瘍 EV による T 細胞老化・Treg 誘導・CD8 デコイ等の免疫回避機構を標的化する戦略 (抗 PD-L1 EV、抗 TSPAN8、抗 β2 抗体、メラノソーム分泌阻害) はほぼ前臨床段階に留まる
EV が免疫賦活メディエーターとして働く文脈 (AT-EV による抗原提示 DNA 転送 = acellular immunotherapy、神経芽腫 EV / SyntEVs による CAR-T 増強) の臨床転用には、HLA ミスマッチ同種 EV の安全性、エピソーム発現の持続性・制御性、量産プロトコルの確立が必要
Wang et al. CancerCell 2026 — Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
Xue et al. CancerCellInt 2026 — Tissue-derived extracellular vesicles comparing ts-EVs and te-EVs in extraction, characteristics and research trends
Hudson et al. CancerLett 2026 — Human neural stem cell-derived extracellular vesicles improve cognitive function following glioma chemoradiation therapy
Chayama et al. Cell 2026 — Physiological brain clearance architecture revealed by neuronal protein tracing
Peng et al. CellMolBiolLett 2026 — Lactate-activated astrocytes promote NSCLC brain metastasis through extracellular vesicle-mediated miR-8085trim67elk1
Zhang et al. CellRepMed 2026 — Artificial exosomes synergistically reshape sepsis immune homeostasis by modulating neutrophil fate and blocking
Chen et al. FrontImmunol 2026 — Exosomal POSTN from cancer-associated fibroblasts drives progression of microinvasive lung adenocarcinoma insights from
Pontis et al. JExpClinCancerRes 2026 — Circulating extracellular vesicles from early-stage lung cancer patients trigger endothelial activation to drive
De et al. JExtracellVesicles 2026 — Characterizing the fate of anti-CS1 nanobody displaying extracellular vesicles in multiple myeloma
Liu et al. JNanobiotechnology 2026 — Overcoming blood-brain barrier and chemoresistance in glioblastoma by angiopep-2-modified NK cell-derived extracellular
Cai et al. MolCancer 2026 — Extracellular vesicles in solid tumors from tumor ecology to engineered therapeutics
You et al. NatAging 2026 — Brain endothelial cell-derived extracellular vesicles (c-beevs) as a promising biomarker for brain vascular pathology
Tian et al. NatBiomedEng 2026 — Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for duchenne muscular dystrophy
Wen et al. NatBiotechnol 2026 — Spatially resolved profiling of extracellular vesicles in tissues with spatial-EV-seq
Goh et al. NatCommun 2026 — Sarcopenia promotes tumorigenesis by disrupting NOTCH-SDC2-regulated biogenesis of muscle-derived extracellular vesicles
Richter et al. STARProtoc 2025 — Protocol for the isolation of human neutrophil-derived extracellular vesicles for characterization and functional
Giudice et al. SciTranslMed 2025 — Target antigen-displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma
Ma et al. SciTranslMed 2025 — Tumor extracellular vesicle-derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming
Zhongyu et al. BiomedPharmacother 2024 — Review of pre-metastatic niches induced by osteosarcoma-derived extracellular vesicles in lung metastasis A potential
Casanova-Salas et al. CancerCell 2024 — Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution
Jones et al. BMCBioinformatics 2023 — Tidyproteomics An open-source R package and data object for quantitative proteomics post analysis and visualization
Ochkasova et al. IntJMolSci 2023 — Two edges in our knowledge on the functions of ribosomal proteins the revealed contributions of their regions to
Mugoni et al. JExtracellBiol 2023 — Integrating extracellular vesicle and circulating cell-free DNA analysis using a single plasma aliquot improves the
Blavier et al. JExtracellVesicles 2023 — The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory
Shin et al. Biomaterials 2022 — Novel antitumor therapeutic strategy using CD4+ T cell-derived extracellular vesicles
Wang et al. CancerImmunolImmunother 2022 — Tumor derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1 fibroblast and CCR8 Treg cell…
Kudo et al. CellMetab 2022 — Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma
Breitwieser et al. IntJMolSci 2022 — Detailed characterization of small extracellular vesicles from different cell types based on tetraspanin composition by
Glemain et al. JAutoimmun 2022 — Neutrophil-derived extracellular vesicles induce endothelial inflammation and damage through the transfer of miRNAs
Jung et al. JExtracellVesicles 2022 — Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer
Leary et al. JExtracellVesicles 2022 — Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes
Yates et al. JExtracellVesicles 2022 — In sickness and in health the functional role of extracellular vesicles in physiology and pathology in vivo part I
Yates et al. JExtracellVesicles 2022 — In sickness and in health the functional role of extracellular vesicles in physiology and pathology in vivo part II
Esposti et al. IntJMolSci 2021 — Exosomes from plasma of neuroblastoma patients contain doublestranded DNA reflecting the muational status of parental…
Gorji-Bahri et al. JCellBiochem 2021 — RAB5A is associated with genes involved in exosome secretion integration of bioinformatics analysis and experimental
Kadota et al. JExtracellVesicles 2021 — Human bronchial epithelial cell-derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of
Kugeratski et al. NatCellBiol 2021 — Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a
Zhang et al. NatCellBiol 2021 — Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets
Mariscal et al. JExtracellVesicles 2020 — Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived
Kim et al. JCellSci 2019 — Deficiency of Fhl2 leads to delayed neuronal cell migration and premature astrocyte differentiation
Lee et al. JExpMed 2019 — Caveolin-1 selectively regulates microRNA sorting into microvesicles after noxious stimuli
Lazaro et al. JExtracellVesicles 2019 — Ibanez-DNA analysis of low-and high-density fractions defines heterogeneous subpopulations of small extracellular ves…
Skotland et al. JLipidRes 2019 — Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology
Tian et al. ACSNano 2018 — Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry
Castillo et al. AnnOncol 2018 — Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer
Pavlyukov et al. CancerCell 2018 — Apoptotic cell-derived extracellular vesicles promote malignancy of glioblastoma via intercellular transfer of splicing
Thery et al. JExtracellVesicles 2018 — Minimal information for studies of extracellular vesicles 2018 (MISEV2018) a position statement of the international
Sansone et al. ProcNatlAcadSciUSA 2017 — Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant
Bonjoch et al. SciRep 2017 — REG3beta modifies cell tumor function by impairing extracellular vesicle uptake
Chen et al. ACSApplMaterInterfaces 2016 — Imaging and intracellular tracking of cancer-derived exosomes using single-molecule localization-based super-resolution
Heusermann et al. JCellBiol 2016 — Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER
Wang et al. MolTher 2016 — Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis
Yim et al. NatCommun 2016 — Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein
Votteler et al. Nature 2016 — Designed proteins induce the formation of nanocage-containing extracellular vesicles
vanderVos et al. NeuroOncol 2016 — Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microgliamacrophages in the brain
Hurwitz et al. Oncotarget 2016 — Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers
Sanchez et al. Oncotarget 2016 — Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes
Kowal et al. ProcNatlAcadSciUSA 2016 — Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
Nakase et al. SciRep 2016 — Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by
Srinivasan et al. SciRep 2016 — Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node
Willms et al. SciRep 2016 — Cells release subpopulations of exosomes with distinct molecular and biological properties
Chiu et al. Small 2016 — A single-cell assay for time lapse studies of exosome secretion and cell behaviors
Soni et al. Thorax 2016 — Alveolar macrophage-derived microvesicles mediate acute lung injury
Shurtleff et al. eLife 2016 — Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction
Zomer et al. Cell 2015 — In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior
Saari et al. JControlRelease 2015 — Microvesicle-and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer…
Smith et al. JExtracellVesicles 2015 — Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content
Colombo et al. JCellSci 2013 — Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of
Bijnsdorp et al. JExtracellVesicles 2013 — Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic
Deng et al. AmJPathol 2012 — Tumor cell cross talk with tumor-associated leukocytes leads to induction of tumor exosomal fibronectin and promotes
DiVizio et al. AmJPathol 2012 — Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease
Bobrie et al. CancerRes 2012 — Rab27a supports exosome-dependent and-independent mechanisms that modify the tumor microenvironment and can promote
Luga et al. Cell 2012 — Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration
Dowlatshahi et al. DevCell 2012 — ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding
Bobrie et al. JExtracellVesicles 2012 — Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations
Choi et al. JExtracellVesicles 2012 — Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells
Nabhan et al. ProcNatlAcadSciUSA 2012 — Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by
Hood et al. CancerRes 2011 — Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis
vanNiel et al. DevCell 2011 — The tetraspanin CD63 regulates ESCRT-independent and-dependent endosomal sorting during melanogenesis
Mayers et al. JBiolChem 2011 — ESCRT-0 assembles as a heterotetrameric complex on membranes and binds multiple ubiquitinylated cargoes simultaneously
Antonyak et al. ProcNatlAcadSciUSA 2011 — Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to
Morelli et al. Blood 2004 — Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells
Kuroda et al. NatCellBiol 2004 — Rab27A-binding protein Slp2-a is required for peripheral melanosome distribution and elongated cell shape in melanocytes
Mears et al. Proteomics 2004 — Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass